MTOR and neoplasm: Genetic inactivation of autophagy in tumor cells can also enhance the efficacy of immune checkpoint inhibitors in mouse tumor models (56), in which autophagy is activated in tumor cells by inhibiting mTOR signaling; this promotes tumor cell escape from T cell-mediated killing.